Pesce, Francesco
Pasculli, Domenico
Pasculli, Giuseppe
De Nicola, Luca
Cozzolino, Mario
Granata, Antonio
Gesualdo, Loreto http://orcid.org/0000-0002-4861-0911
Funding for this research was provided by:
Università degli Studi di Bari Aldo Moro
Article History
Received: 25 February 2022
Accepted: 10 May 2022
First Online: 14 June 2022
Declarations
:
: FP received fees from AstraZeneca for lectures. DP, GP have no disclosure. LDN received fees from Astellas, AstraZeneca, Bayer, Novo Nordisk and Vifor for lectures and scientific consultations MC received research funding from Abbvie, Baxter, Keryx, and Shire; reports receiving honoraria from Abbvie, Amgen, Astrazeneca, Baxter, Shire, and Vifor-Pharma; reports serving as a scientific advisor or member of and reports speakers bureau for Abbvie, Amgen, Keryx, Shire, and Vifor Pharma GA received fees from AstraZeneca for lectures LG received research fundings from Abionyx, Sanofi, and received fees from Fresenius, Estor, Werfen, Astellas, AstraZeneca, Travere, Sandoz, Baxter, Mundipharma, Pharmadoc, Retrophin, GSK, Novartis, Chinook.
: Patient consent was not required given the non-interventional/observational nature of the study and the fact that data were provided by the GPs to the investigators as fully anonymised (hence not allowing the study investigators to reconstruct the identity of study participants). Notice was not given to the local Ethics' Committee /Institutional Review Board.